Michael Horowitz Selected Research

Blood Glucose (Blood Sugar)

10/2022	The Effect of a Liberal Approach to Glucose Control in Critically Ill Patients with Type 2 Diabetes: A Multicenter, Parallel-Group, Open-Label Randomized Clinical Trial.
5/2021	Comparative Effects of the Branched-Chain Amino Acids, Leucine, Isoleucine and Valine, on Gastric Emptying, Plasma Glucose, C-Peptide and Glucagon in Healthy Men.
4/2021	Effects of Bitter Substances on GI Function, Energy Intake and Glycaemia-Do Preclinical Findings Translate to Outcomes in Humans?
1/2021	Comparative Effects of Intragastric and Intraduodenal Administration of Quinine on the Plasma Glucose Response to a Mixed-Nutrient Drink in Healthy Men: Relations with Glucoregulatory Hormones and Gastric Emptying.
11/2020	Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin.
6/2020	Study protocol and statistical analysis plan for the Liberal Glucose Control in Critically Ill Patients with Pre-existing Type 2 Diabetes (LUCID) trial.
1/2020	Mechanism of glucose-lowering by metformin in type 2 diabetes: Role of bile acids.
11/2019	Effects of Duodenal Infusion of Lauric Acid and L-Tryptophan, Alone and Combined, on Fasting Glucose, Insulin and Glucagon in Healthy Men.
1/2019	A whey/guar "preload" improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: A 12-week, single-blind, randomized, placebo-controlled trial.
10/2018	Effects of starvation and short-term refeeding on gastric emptying and postprandial blood glucose regulation in adolescent girls with anorexia nervosa.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Horowitz Research Topics

Disease

100	Type 2 Diabetes Mellitus (MODY) 11/2022 - 08/2002
38	Critical Illness (Critically Ill) 10/2022 - 01/2006
24	Obesity 01/2022 - 08/2002
19	Hypotension (Low Blood Pressure) 08/2021 - 04/2002
16	Hyperglycemia 01/2022 - 08/2003
14	Aneurysm (Aneurysms) 11/2021 - 07/2003
14	Nausea 01/2021 - 02/2003
13	Diabetes Mellitus 06/2022 - 03/2002
12	Gastroparesis 12/2019 - 01/2002
11	Hypoglycemia (Reactive Hypoglycemia) 10/2022 - 10/2003
11	Weight Loss (Weight Reduction) 01/2022 - 11/2003
11	Malnutrition (Nutritional Deficiencies) 11/2018 - 08/2003
10	Body Weight (Weight, Body) 03/2021 - 04/2004
8	Insulin Resistance 01/2021 - 03/2008
7	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 02/2004
7	Overweight 01/2021 - 06/2009
7	Glucose Intolerance 05/2020 - 10/2008
7	Hemifacial Spasm 06/2017 - 10/2011
6	Stroke (Strokes) 12/2012 - 01/2005
6	Thrombosis (Thrombus) 05/2012 - 09/2004
5	Neoplasms (Cancer) 01/2016 - 08/2002
5	Osteoporosis 07/2009 - 01/2004
4	Intracranial Aneurysm (Cerebral Aneurysm) 11/2021 - 05/2004
4	Vomiting 01/2021 - 02/2003
4	Morbid Obesity 10/2019 - 01/2006
4	Cystic Fibrosis (Mucoviscidosis) 01/2019 - 05/2011
4	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2014 - 10/2008
4	Hemorrhage 07/2011 - 11/2003
4	Vitamin D Deficiency 11/2008 - 05/2007
3	Weight Gain 10/2019 - 02/2013
3	Pain (Aches) 01/2016 - 10/2004
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2012 - 09/2004
3	Diarrhea 06/2012 - 02/2003
3	Bone Resorption 07/2009 - 07/2004
2	Anorexia 01/2022 - 08/2003
2	Anorexia Nervosa 12/2018 - 10/2018
2	Hyperinsulinism (Hyperinsulinemia) 01/2018 - 03/2015

Drug/Important Bio-Agent (IBA)

99	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 01/2002
48	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 08/2002
42	Blood Glucose (Blood Sugar)IBA 10/2022 - 08/2002
40	Insulin (Novolin)FDA Link 11/2021 - 08/2002
27	IncretinsIBA 05/2021 - 08/2002
25	Hormones (Hormone)IBA 01/2022 - 08/2002
19	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2009
13	CarbohydratesIBA 01/2021 - 08/2002
13	Metformin (Glucophage)FDA LinkGeneric 11/2020 - 08/2014
12	Glucagon (Glukagon)FDA Link 01/2020 - 01/2009
10	Whey ProteinsIBA 05/2021 - 09/2009
9	lixisenatideIBA 06/2022 - 02/2013
9	Peptides (Polypeptides)IBA 08/2021 - 08/2002
8	Exenatide (Byetta)FDA Link 01/2021 - 11/2008
8	CalciumIBA 07/2009 - 01/2004
7	LipidsIBA 01/2016 - 03/2006
6	Glucagon-Like Peptide-1 ReceptorIBA 11/2021 - 08/2013
6	Cholecystokinin (Pancreozymin)IBA 08/2013 - 01/2006
5	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 04/2013
5	GhrelinIBA 12/2018 - 08/2003
5	Peptide YYIBA 12/2018 - 01/2006
5	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2016 - 06/2009
4	AcidsIBA 11/2022 - 05/2004
4	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 03/2021 - 08/2012
4	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021 - 05/2006
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 03/2002
4	VildagliptinIBA 01/2020 - 04/2016
4	Vitamin D FDA LinkGeneric 11/2008 - 05/2007
3	Sitagliptin Phosphate (Januvia)FDA Link 01/2020 - 07/2013
3	guar gum (guaran)IBA 12/2019 - 07/2003
3	Sweetening Agents (Sweeteners)IBA 10/2019 - 06/2011
3	AntralIBA 01/2016 - 06/2007
3	Erythromycin (Erycette)FDA LinkGeneric 06/2013 - 01/2010
3	Botulinum Toxins (Botulinum Toxin)IBA 06/2013 - 10/2011
3	Biomarkers (Surrogate Marker)IBA 12/2012 - 05/2004
3	Pharmaceutical PreparationsIBA 06/2012 - 01/2007
3	Hypoglycemic Agents (Hypoglycemics)IBA 06/2009 - 02/2003
3	hydroxide ionIBA 11/2008 - 04/2004
3	25-hydroxyvitamin DIBA 10/2008 - 06/2005
3	Parathyroid Hormone (Parathormone)IBA 10/2008 - 04/2004
3	XenonIBA 01/2008 - 01/2005
2	Dietary Fats (Dietary Fat)IBA 01/2022 - 09/2007
2	semaglutideIBA 10/2021 - 01/2021
2	Liraglutide FDA Link 01/2021 - 08/2012
2	Tryptophan (L-Tryptophan)FDA Link 01/2021 - 08/2020
2	Edetic Acid (EDTA)FDA Link 01/2020 - 08/2005
2	C-PeptideIBA 01/2020 - 02/2006
2	ElectrolytesIBA 11/2018 - 06/2013
2	AntibodiesIBA 01/2016 - 04/2008
2	EnzymesIBA 07/2014 - 05/2011

Therapy/Procedure

35	Therapeutics 01/2022 - 08/2003
18	Glycemic Control 11/2021 - 03/2002
14	Enteral Nutrition (Feeding, Tube) 01/2022 - 05/2008
11	Stents 01/2012 - 11/2003
8	Microvascular Decompression Surgery 06/2017 - 04/2002
6	Catheters 09/2012 - 08/2005
4	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2017 - 01/2006
4	Intravenous Infusions 06/2015 - 02/2006
3	Aftercare (After-Treatment) 01/2021 - 11/2005
2	Cholecystectomy 01/2022 - 06/2006
2	Critical Care (Surgical Intensive Care) 01/2021 - 01/2016
2	Drug Therapy (Chemotherapy) 11/2020 - 06/2013
2	Enzyme Replacement Therapy 10/2019 - 07/2014